Lab
FT Medical Group, LLC
FT Medical Group, LLC was paid $178K by Medicaid between Sep 2020 and Sep 2023, across 12 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 85% of everything it billed.
33Billing provider infoFT MEDICAL GROUP, LLC
ATLANTA, GA 30315
ATLANTA, GA 30315
33aNPI1467072231assigned 04/22/2020
33bProvider typeClinical Medical Laboratory
28Total paid$178K
24GClaims5,271
24DCodes billed12
24AFirst – last monthSep 2020 – Sep 2023
Compared with peers
Next to other Clinical Medical Laboratory providers in Georgia
Rank by total paid#34 of 66
Median peer was paid$178K
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,225 | $73K | |
| 2021 | 619 | $18K | |
| 2022 | 3,144 | $86K | |
| 2023 | 283 | $600.82 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 85% | 2,003 | 807 | $151K |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | 13% | 1,485 | 634 | $23K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 309 | 83 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,052 | 462 | $857.50 |
| 80053 | Comprehensive metabolic panel | <1% | 100 | 67 | $427.69 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 54 | 29 | $124.24 |
| 85027 | <1% | 55 | 31 | $106.40 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 24 | 13 | $42.10 |
| 80061 | Lipid panel | <1% | 22 | 12 | $34.83 |
| 36415 | Collection of venous blood by venipuncture | <1% | 81 | 36 | $4.42 |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 0% | 65 | 39 | $0.00 |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 0% | 21 | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFARRAR, DARRYLE (CHIEF OPERATING OFFICER)